Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Two Center Evaluation of the Safety and Efficacy of Topical Nasal rEV131 Versus rEV131 Vehicle (Placebo)in the Prevention of the Signs and Symptoms of Allergic Rhinitis Induced by Nasal Allergen Challenge

NCT00247520 is registered in ClinicalTrials.gov with Evolutec Group as lead sponsor.

NCT NCT00247520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00247520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Two Center Evaluation of the Safety and Efficacy of Topical Nasal rEV131 Versus rEV131 Vehicle (Placebo)in the Prevention of the Signs and Symptoms of Allergic Rhinitis Induced by Nasal Allergen Challenge
Lead sponsor
Evolutec Group
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2005
Completion date
August 31, 2005
Enrollment
112
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hay fever